Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
cost effectiveness analysis
Email alerts
cost effectiveness analysis
Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
Christoph
Lohan
,
Alex
Diamantopoulos
,
Corinne
LeReun
,
Emily
Wright
,
Natalie
Bohm
,
Laura Marie
Sawyer
BMJ Open Gastroenterology
Jul 2019,
6
(1)
e000302;
DOI:
10.1136/bmjgast-2019-000302
Special collections
Editor's choice
Guidelines, Recommendations and Consensus Statements
Open access
(14)
Press releases
